Case number 1:18-cv-01562
AstraZeneca AB et al v. Mylan Pharmaceuticals Inc. et al > Documents
| Date Field | Doc. No. | Description (Pages) |
|---|---|---|
| Jul 9, 2020 | 145 | Motion to Compel (2) |
| Jul 9, 2020 | 144 | Motion for Leave to Appear Pro Hac Vice (2) |
| Jul 9, 2020 | 110 | Motion for Leave to Appear Pro Hac Vice (2) |
| Jul 9, 2020 | 38 | Motion for Leave to Appear Pro Hac Vice (2) |
| Jul 9, 2020 | 32 | Motion to Transfer Case (1) |
| Jul 9, 2020 | 19 | Motion to Dismiss for Failure to State a Claim (2) |
| Jul 9, 2020 | 11 | Motion for Leave to Appear Pro Hac Vice (2) |
| Mar 19, 2020 | N/A | Oral Order (0) Docket Text: ORAL ORDER: Since this matter was transferred to the Northern District of West Virginia, the mediation scheduled for 4/22/20 and submission due date with Judge Thynge are cancelled. Ordered by Judge Mary Pat Thynge on 3/19/20. (cak) |
| Nov 4, 2019 | N/A | Case Transferred Out to Another District (0) Docket Text: Case transferred to the United States District Court for the Northern District of West Virginia. (nmf) |
| Nov 4, 2019 | N/A | Remark (0) Docket Text: Remark : : Case transferred from Delaware has been opened in Northern District of West Virginia as case 1:19-cv-00203, filed 11/04/2019. (rwc) |
| Nov 1, 2019 | 165 | Notice of Service (2) Docket Text: NOTICE OF SERVICE of Defendants Mylan Pharmaceuticals Inc.'s and 3M Company's First Amended Initial Disclosures Pursuant to Fed. R. Civ. P. 26(a)(1) filed by 3M Company, Mylan Pharmaceuticals Inc..(Ewing, Alexandra) |
| Nov 1, 2019 | 166 | Notice of Service (2) Docket Text: NOTICE OF SERVICE of (1) Defendants Mylan Pharmaceuticals Inc.'s and 3M Company's First Supplemental Objections and Responses to Plaintiffs' First Set of Common Interrogatories (Nos. 1-6) and (2) Defendants Mylan Pharmaceuticals Inc.'s and 3M Company's First Supplemental Objections and Responses to Plaintiffs' First Set of Specific Interrogatories to Mylan Defendant Group (Nos. 1-6) filed by 3M Company, Mylan Pharmaceuticals Inc..(Ewing, Alexandra) |
| Oct 31, 2019 | 164 | Notice of Service (2) Docket Text: NOTICE OF SERVICE of Defendant Mylan Pharmaceuticals Inc.'s Objections and Responses to Plaintiffs' Notice of Deposition Under Fed. R. Civ. P. 30(b)(6) filed by Mylan Pharmaceuticals Inc..(Ewing, Alexandra) |
| Oct 22, 2019 | 162 | Notice (Other) (2) Docket Text: NOTICE of Withdrawal of Plaintiffs' Motion to Compel by AstraZeneca AB, AstraZeneca Pharmaceuticals LP re [145] MOTION to Compel , [146] Letter (Silver, Daniel) |
| Oct 22, 2019 | 163 | Redacted Document (4) Docket Text: REDACTED VERSION of [146] Letter by AstraZeneca AB, AstraZeneca Pharmaceuticals LP. (Silver, Daniel) |
| Oct 18, 2019 | 156 | Memorandum Opinion (26) Docket Text: MEMORANDUM OPINION Signed by Judge Colm F. Connolly on 10/18/2019. (nmf) |
| Oct 18, 2019 | 157 | Order on Motion to Transfer Case (2) Docket Text: ORDER granting [32] Motion to Transfer Case; finding as moot [32] Motion to Dismiss ; denying [19] Motion to Dismiss. Signed by Judge Colm F. Connolly on 10/18/2019. (nmf) |
| Oct 18, 2019 | 158 | Notice of Service (2) Docket Text: NOTICE OF SERVICE of Defendant 3M Company's Objections and Responses to Plaintiffs' Notice of Deposition Under Fed. R. Civ. P. 30(b)(6) filed by 3M Company.(Ewing, Alexandra) |
| Oct 18, 2019 | 159 | Notice of Service (4) Docket Text: NOTICE OF SERVICE of PLAINTIFFS OBJECTIONS AND RESPONSES TO DEFENDANTS MYLAN PHARMACEUTICALS, INC., 3M COMPANY, TEVA PHARMACEUTICALS USA, INC., AND CATALENT PHARMA SOLUTIONS LLCS FIRST NOTICE OF DEPOSITION OF ASTRAZENECA AB AND ASTRAZENECA PHARMACEUTICALS LP PURSUANT TO FED. R. CIV. P. 30(b)(6) filed by AstraZeneca AB, AstraZeneca Pharmaceuticals LP.(Silver, Daniel) |
| Oct 18, 2019 | 160 | Notice of Service (2) Docket Text: NOTICE OF SERVICE of a subpoena duces tecum directed to Morgan, Lewis & Bockius LLP and a subpoena ad testificandum directed to Gregory T. Lowen filed by Catalent Pharma Solutions, LLC, Teva Pharmaceuticals USA, Inc..(Hoeschen, Nathan) |
| Oct 18, 2019 | 161 | Letter (2) Docket Text: Letter to The Honorable Colm F. Connolly from Frederick L. Cottrell, III regarding transfer of case and further redactions - re [152] Letter. (Cottrell, Frederick) |
| Oct 17, 2019 | N/A | Remark (0) |
| Oct 17, 2019 | 153 | Redacted Document (14) Docket Text: REDACTED VERSION of [114] Notice to Take Deposition by AstraZeneca AB, AstraZeneca Pharmaceuticals LP. (Silver, Daniel) |
| Oct 17, 2019 | 154 | Redacted Document (16) Docket Text: REDACTED VERSION of [116] Notice (Other) by AstraZeneca AB, AstraZeneca Pharmaceuticals LP. (Silver, Daniel) |
| Oct 17, 2019 | 155 | Redacted Document (16) Docket Text: REDACTED VERSION of [117] Notice (Other) by AstraZeneca AB, AstraZeneca Pharmaceuticals LP. (Silver, Daniel) |
| Oct 16, 2019 | 149 | Redacted Document (4) |
| Oct 16, 2019 | 149 | Exhibit A-C (16) |
| Oct 16, 2019 | 150 | Notice of Service (4) Docket Text: NOTICE OF SERVICE of Plaintiffs' Response to Defendants' Invalidity Contentions filed by AstraZeneca AB, AstraZeneca Pharmaceuticals LP.(Silver, Daniel) |
| Oct 16, 2019 | 151 | Redacted Document (30) Docket Text: REDACTED VERSION of [39] Answering Brief in Opposition, by AstraZeneca AB, AstraZeneca Pharmaceuticals LP. (Silver, Daniel) |
| Oct 16, 2019 | 152 | Letter (1) Docket Text: Letter to The Honorable Colm F. Connolly from Frederick L. Cottrell, III regarding Further redactions to D.I. 41 - re [41] Declaration. (Cottrell, Frederick) |
| Oct 16, 2019 | 149 | Main Document (4) Docket Text: REDACTED VERSION of [147] Letter, to The Honorable Colm F. Connolly from Frederick L. Cottrell, III regarding Response to Plaintiffs' letter of October 14, 2019 regarding discovery disputes by 3M Company, Mylan Pharmaceuticals Inc.. (Attachments: # (1) Exhibit A-C)(Cottrell, Frederick) |
| Oct 15, 2019 | N/A | SO ORDERED (0) Docket Text: SO ORDERED, re (144 in 1:18-cv-01562-CFC, 98 in 1:18-cv-01685-CFC) MOTION for Pro Hac Vice Appearance of Attorney Megan P. Keane filed by AstraZeneca Pharmaceuticals LP, AstraZeneca AB. Signed by Judge Colm F. Connolly on 10/15/2019. Associated Cases: 1:18-cv-01562-CFC, 1:18-cv-01685-CFC(fms) |
| Oct 15, 2019 | 148 | Notice of Service (2) Docket Text: NOTICE OF SERVICE of Noninfringement Contentions filed by 3M Company, Mylan Pharmaceuticals Inc..(Ewing, Alexandra) |
| Oct 14, 2019 | N/A | CORRECTING ENTRY: (0) Docket Text: CORRECTING ENTRY: DI # 41 was placed back under seal by the Intake Supervisor pursuant to e-mail received from Counsel per Mylan. (rwc) |
| Oct 14, 2019 | 145 | Text of Proposed Order (1) |
| Oct 14, 2019 | 145 | Averment of Counsel (1) |
| Oct 14, 2019 | 145 | Main Document (2) Docket Text: MOTION to Compel - filed by AstraZeneca AB, AstraZeneca Pharmaceuticals LP. (Attachments: # (1) Text of Proposed Order, # (2) Averment of Counsel)(Silver, Daniel) |
| Oct 11, 2019 | N/A | Oral Order (0) |
| Oct 11, 2019 | N/A | Oral Order (0) |
| Oct 11, 2019 | N/A | Oral Order (0) |
| Oct 10, 2019 | N/A | Oral Argument (0) Docket Text: Minute Entry for proceedings held before Judge Colm F. Connolly - Oral Argument held on 10/10/2019. (Court Reporter V. Gunning.) (nmf) |
| Oct 10, 2019 | 144 | Certification for Megan P. Keane (1) |
| Oct 10, 2019 | 144 | Main Document (2) Docket Text: MOTION for Pro Hac Vice Appearance of Attorney Megan P. Keane - filed by AstraZeneca AB, AstraZeneca Pharmaceuticals LP. (Attachments: # (1) Certification for Megan P. Keane)(Silver, Daniel) |
| Oct 9, 2019 | N/A | SO ORDERED (0) |
| Oct 9, 2019 | 141 | Claim Construction Opening Brief (30) Docket Text: Joint CLAIM CONSTRUCTION OPENING BRIEF filed by AstraZeneca AB, AstraZeneca Pharmaceuticals LP. (Joyce, Alexandra) |
| Oct 9, 2019 | 142 | Appendix (8) |
| Oct 9, 2019 | 142 | Exhibit J1 (28) |
| Oct 9, 2019 | 142 | Exhibits P1 - P11DD (450) |
| Oct 9, 2019 | 142 | Exhibits D1 - D4 (323) |
| Oct 9, 2019 | 143 | Notice (Other) (2) Docket Text: Joint NOTICE of Service of Case Compendium In Support of Joint Claim Construction Brief by AstraZeneca AB, AstraZeneca Pharmaceuticals LP re (141 in 1:18-cv-01562-CFC) Claim Construction Opening Brief, (95 in 1:18-cv-01685-CFC) Claim Construction Opening Brief (Joyce, Alexandra) |
| Oct 9, 2019 | 142 | Main Document (8) Docket Text: Joint APPENDIX re (141 in 1:18-cv-01562-CFC) Claim Construction Opening Brief, (95 in 1:18-cv-01685-CFC) Claim Construction Opening Brief by AstraZeneca AB, AstraZeneca Pharmaceuticals LP. (Attachments: # (1) Exhibit J1, # (2) Exhibits P1 - P11DD, # (3) Exhibits D1 - D4)(Joyce, Alexandra) |
| Oct 8, 2019 | 132 | Notice of Service (2) Docket Text: NOTICE OF SERVICE of a subpoena duces tecum on Fish & Richardson PC and a subpoena ad testificandum on Janis K. Fraser filed by Catalent Pharma Solutions, LLC, Teva Pharmaceuticals USA, Inc..(Keller, Karen) |
| Oct 8, 2019 | 133 | Notice to Take Deposition (2) Docket Text: NOTICE to Take Deposition of Annette Purrington on October 29, 2019 filed by AstraZeneca AB, AstraZeneca Pharmaceuticals LP.(Silver, Daniel) |
| Oct 8, 2019 | 134 | Notice to Take Deposition (2) Docket Text: NOTICE to Take Deposition of Jack Rasmussen on October 25, 2019 filed by AstraZeneca AB, AstraZeneca Pharmaceuticals LP.(Silver, Daniel) |
| Oct 8, 2019 | 135 | Notice to Take Deposition (2) Docket Text: NOTICE to Take Deposition of Kim Kriesel on October 22, 2019 filed by AstraZeneca AB, AstraZeneca Pharmaceuticals LP.(Silver, Daniel) |
| Oct 8, 2019 | 136 | Notice to Take Deposition (2) Docket Text: NOTICE to Take Deposition of Martin Wilson on October 23, 2019 filed by AstraZeneca AB, AstraZeneca Pharmaceuticals LP.(Silver, Daniel) |
| Oct 8, 2019 | 137 | Notice to Take Deposition (2) Docket Text: NOTICE to Take Deposition of Rupi Pannu on October 21, 2019 filed by AstraZeneca AB, AstraZeneca Pharmaceuticals LP.(Silver, Daniel) |
| Oct 8, 2019 | 138 | Notice to Take Deposition (2) Docket Text: NOTICE to Take Deposition of Stephen Stein on October 31, 2019 filed by AstraZeneca AB, AstraZeneca Pharmaceuticals LP.(Silver, Daniel) |
| Oct 8, 2019 | 139 | Notice to Take Deposition (2) Docket Text: NOTICE to Take Deposition of Wayne Talton on October 24, 2019 filed by AstraZeneca AB, AstraZeneca Pharmaceuticals LP.(Silver, Daniel) |
| Oct 8, 2019 | 140 | Stipulation to EXTEND Time (2) Docket Text: Joint STIPULATION TO EXTEND TIME the deadline for the Parties to submit their Joint Claim Construction Brief to Wednesday, October 9, 2019 (from Tuesday, October 8, 2019) - filed by AstraZeneca AB, AstraZeneca Pharmaceuticals LP. (Joyce, Alexandra) |
| Oct 7, 2019 | 131 | Notice of Service (2) Docket Text: NOTICE OF SERVICE of Defendants' Sur-Reply Markman Brief filed by Catalent Pharma Solutions, LLC, Teva Pharmaceuticals USA, Inc..(Hoeschen, Nathan) |
| Oct 4, 2019 | N/A | CORRECTING ENTRY: (0) |
| Oct 4, 2019 | 121 | Letter (2) |
| Oct 4, 2019 | 121 | Exhibit A (7) |
| Oct 4, 2019 | 121 | Exhibit B (6) |
| Oct 4, 2019 | 122 | Notice to Take Deposition (2) Docket Text: NOTICE to Take Deposition of Domenick Fanelli on October 15. 2019 filed by Catalent Pharma Solutions, LLC, Teva Pharmaceuticals USA, Inc..(Hoeschen, Nathan) |
| Oct 4, 2019 | 123 | Notice to Take Deposition (2) Docket Text: NOTICE to Take Deposition of Nayna Govind on October 28, 2019 filed by Catalent Pharma Solutions, LLC, Teva Pharmaceuticals USA, Inc..(Hoeschen, Nathan) |
| Oct 4, 2019 | 124 | Notice to Take Deposition (2) Docket Text: NOTICE to Take Deposition of Darren Hodson on October 24, 2019 filed by Catalent Pharma Solutions, LLC, Teva Pharmaceuticals USA, Inc..(Hoeschen, Nathan) |
| Oct 4, 2019 | 125 | Notice to Take Deposition (2) Docket Text: NOTICE to Take Deposition of Andy Ludzik on October 21, 2019 filed by Catalent Pharma Solutions, LLC, Teva Pharmaceuticals USA, Inc..(Hoeschen, Nathan) |
| Oct 4, 2019 | 126 | Notice to Take Deposition (2) Docket Text: NOTICE to Take Deposition of Maria Marlow on November 1, 2019 filed by Catalent Pharma Solutions, LLC, Teva Pharmaceuticals USA, Inc..(Hoeschen, Nathan) |
| Oct 4, 2019 | 127 | Notice to Take Deposition (2) Docket Text: NOTICE to Take Deposition of Jorgen Rasmussen on October 30, 2019 filed by Catalent Pharma Solutions, LLC, Teva Pharmaceuticals USA, Inc..(Hoeschen, Nathan) |
| Oct 4, 2019 | 128 | Notice to Take Deposition (2) Docket Text: NOTICE to Take Deposition of Gary Rowles on October 18, 2019 filed by Catalent Pharma Solutions, LLC, Teva Pharmaceuticals USA, Inc..(Hoeschen, Nathan) |
| Oct 4, 2019 | 129 | Notice to Take Deposition (2) Docket Text: NOTICE to Take Deposition of Jonas Sibomana on October 17, 2019 filed by Catalent Pharma Solutions, LLC, Teva Pharmaceuticals USA, Inc..(Hoeschen, Nathan) |
| Oct 4, 2019 | 130 | Notice to Take Deposition (2) Docket Text: NOTICE to Take Deposition of Frank Trudo on October 16, 2019 filed by Catalent Pharma Solutions, LLC, Teva Pharmaceuticals USA, Inc..(Hoeschen, Nathan) |
| Oct 4, 2019 | 121 | Main Document (2) Docket Text: Letter to Honorable Colm F. Connolly from Frederick L. Cottrell, III regarding Supplemental Authority. (Attachments: # (1) Exhibit A, # (2) Exhibit B)(Cottrell, Frederick) |
| Oct 2, 2019 | 118 | Notice of Service (2) Docket Text: NOTICE OF SERVICE of Defendants Mylan Pharmaceuticals, Inc., 3M Company, Teva Pharmaceuticals USA, Inc., and Catalent Pharma Solutions LLCs First Notice of Deposition of AstraZeneca AB and AstraZeneca Pharmaceuticals LP Pursuant to Fed. R. Civ. P. 30(b)(6) filed by Catalent Pharma Solutions, LLC, Teva Pharmaceuticals USA, Inc..(Hoeschen, Nathan) |
| Oct 2, 2019 | 119 | Notice of Service (2) Docket Text: NOTICE OF SERVICE of First Set of Interrogatories (Nos. 1-3) and Second Set of Requests for Production of Documents and Things (Nos. 123-129) filed by 3M Company, Mylan Pharmaceuticals Inc..(Ewing, Alexandra) |
| Oct 2, 2019 | 120 | Notice of Service (3) Docket Text: NOTICE OF SERVICE of Defendants Mylan Pharmaceuticals Inc., 3M Company, Teva Pharmaceuticals USA, Inc., and Catalent Pharma Solutions, LLC's Third Set of Common Interrogatories to Plaintiffs (Nos. 12-18) filed by 3M Company, Mylan Pharmaceuticals Inc..(Ewing, Alexandra) |
| Oct 1, 2019 | 115 | Notice of Service (2) Docket Text: NOTICE OF SERVICE of (1) Defendants' Second Set of Common Interrogatories to Plaintiffs (No. 11) filed by Catalent Pharma Solutions, LLC, Teva Pharmaceuticals USA, Inc..(Hoeschen, Nathan) |
| Sep 28, 2019 | N/A | CORRECTING ENTRY: (0) |
| Sep 23, 2019 | 113 | Notice of Service (4) Docket Text: NOTICE OF SERVICE of (1) Plaintiffs' Reply Markman Brief and (2) Reply Declaration of Cory J. Berkland, Ph.D. on Claim Construction filed by AstraZeneca AB, AstraZeneca Pharmaceuticals LP.(Silver, Daniel) |
| Sep 20, 2019 | N/A | Oral Order (0) |
| Sep 20, 2019 | N/A | Oral Order (0) |
| Sep 19, 2019 | N/A | Add Attorneys Pro Hac Vice (0) Docket Text: Pro Hac Vice Attorney Brandon M. White for 3M Company and Mylan Pharmaceuticals Inc. added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (mal) |
| Sep 17, 2019 | N/A | SO ORDERED (0) |
| Sep 17, 2019 | N/A | Add Attorneys Pro Hac Vice (0) |
| Sep 17, 2019 | 110 | Certification for Einar Stole (1) |
| Sep 17, 2019 | 111 | Notice to Take Deposition (2) Docket Text: NOTICE to Take Deposition of Dr. Anthony J. Cutie on September 18, 2019 filed by AstraZeneca AB, AstraZeneca Pharmaceuticals LP.(Silver, Daniel) |
| Sep 17, 2019 | 112 | Notice to Take Deposition (2) Docket Text: NOTICE to Take Deposition of Robert Boyd on September 19, 2019 filed by AstraZeneca AB, AstraZeneca Pharmaceuticals LP.(Silver, Daniel) |
| Sep 17, 2019 | 110 | Main Document (2) Docket Text: MOTION for Pro Hac Vice Appearance of Attorney Einar Stole - filed by AstraZeneca AB, AstraZeneca Pharmaceuticals LP. (Attachments: # (1) Certification for Einar Stole)(Silver, Daniel) |
| Sep 16, 2019 | N/A | SO ORDERED (0) |
| Sep 16, 2019 | 108 | Motion for Leave to Appear Pro Hac Vice (3) Docket Text: MOTION for Pro Hac Vice Appearance of Attorney Brandon M. White - filed by 3M Company, Mylan Pharmaceuticals Inc.. (Ewing, Alexandra) |
| Sep 16, 2019 | 109 | Notice of Appearance (1) Docket Text: NOTICE of Appearance by Michael A. Chajon on behalf of 3M Company, Mylan Pharmaceuticals Inc. (Chajon, Michael) |
| Sep 10, 2019 | N/A | SO ORDERED (0) |
| Sep 9, 2019 | 107 | Notice of Service (3) Docket Text: NOTICE OF SERVICE of (1)Defendants Mylan Pharmaceuticals Inc., 3M Company, Teva Pharmaceuticals USA, Inc., and Catalent Pharma Solutions LLCs Answering Claim Construction Brief; (2) Declaration of Dr. Anthony J. Cutie in Support of Defendants Answering Claim Construction Brief; and (3) Declaration of Robert Boyd in Support of Defendants Answering Claim Construction Brief filed by 3M Company, Mylan Pharmaceuticals Inc..(Ewing, Alexandra) |
| Sep 6, 2019 | N/A | Set/Reset Hearings (0) Docket Text: Set Hearings: A Discovery Conference is set per request of counsel for 10/17/2019 at 03:00 PM in Courtroom 4B before Judge Colm F. Connolly. (nmf) |
| Sep 6, 2019 | 106 | Stipulation to EXTEND Time (3) Docket Text: STIPULATION TO EXTEND TIME (1) Service of Defendants Answering Claim Construction Brief is hereby extended to Monday, September 9, 2019 (from Friday, September 6); (2) Service of Plaintiffs Reply Claim Construction Brief is hereby extended to Monday, September 23 (from Tuesday, September 17); (3) Service of Defendants Sur-Reply Claim Construction Brief is hereby extended to Thursday, October 3 (from Friday, September 27); and (4) the deadline to file the Joint Claim Construction Brief is hereby extended to Tuesday, October 8 (from Wednesday, October 2) to - filed by 3M Company, Mylan Pharmaceuticals Inc.. (Ewing, Alexandra) |
| Sep 3, 2019 | N/A | SO ORDERED (0) |
| Aug 30, 2019 | 105 | Stipulation to EXTEND Time (2) Docket Text: STIPULATION TO EXTEND TIME for Joinder of Other Parties and Amendment of Pleadings to September 6, 2019 - filed by 3M Company, Mylan Pharmaceuticals Inc.. (Ewing, Alexandra) |
| Aug 27, 2019 | N/A | SO ORDERED (0) |
| Aug 26, 2019 | 104 | Stipulation to EXTEND Time (2) Docket Text: STIPULATION TO EXTEND TIME for substantial completion of document production to September 6, 2019 - filed by Mylan Pharmaceuticals Inc.. (Ewing, Alexandra) |
| Aug 20, 2019 | 103 | Notice of Service (4) Docket Text: NOTICE OF SERVICE of (1) Plaintiffs Opening Markman Brief; and (2) Declaration of Cory J. Berkland, Ph.D. on Claim Construction filed by AstraZeneca AB, AstraZeneca Pharmaceuticals LP.(Silver, Daniel) |
| Aug 14, 2019 | 102 | Order Setting Mediation Conferences (7) Docket Text: ORDER Setting Mediation Conferences: A Mediation Conference is set for 4/22/2020 at 10:00 AM in Courtroom 2B before Judge Mary Pat Thynge. SEE ORDER FOR DETAILS. Signed by Judge Mary Pat Thynge on 8/14/19. (cak) |
| Aug 13, 2019 | 100 | Letter (2) Docket Text: Letter to The Honorable Colm F. Connolly from Daniel M. Silver, Esq. regarding Responsive Letter - re [94] Order,,,. (Silver, Daniel) |
| Aug 13, 2019 | 101 | Letter (2) Docket Text: Letter to The Honorable Colm F. Connolly from Frederick L. Cottrell, III regarding effect, if any, of merger between Mylan and Upjohn - re [94] Order,,,. (Cottrell, Frederick) |
| Aug 8, 2019 | N/A | Remark (0) |
| Aug 7, 2019 | N/A | SO ORDERED (0) |
| Aug 5, 2019 | 96 | Letter (2) Docket Text: Letter to The Honorable Colm F. Connolly from Daniel M. Silver, Esq. regarding Default Word Limits for Markman Briefs - re (66 in 1:18-cv-01562-CFC) Scheduling Order,,. (Silver, Daniel) |
| Aug 5, 2019 | 97 | Claim Construction Chart (20) |
| Aug 5, 2019 | 97 | Exhibit A-E (108) |
| Aug 5, 2019 | 98 | Motion for Miscellaneous Relief (2) Docket Text: MOTION for Claim Construction re (58 in 1:18-cv-01685-CFC, 97 in 1:18-cv-01562-CFC) Claim Construction Chart - filed by AstraZeneca AB, AstraZeneca Pharmaceuticals LP. (Silver, Daniel) |
| Aug 5, 2019 | 99 | Motion for Miscellaneous Relief (2) Docket Text: MOTION for Claim Construction re (58 in 1:18-cv-01685-CFC, 97 in 1:18-cv-01562-CFC) Claim Construction Chart - filed by 3M Company, Mylan Pharmaceuticals Inc.. (Cottrell, Frederick) |
| Aug 5, 2019 | 97 | Main Document (20) Docket Text: CLAIM Construction Chart by AstraZeneca AB, AstraZeneca Pharmaceuticals LP. (Attachments: # (1) Exhibit A-E)(Silver, Daniel) |
| Aug 2, 2019 | N/A | SO ORDERED (0) |
| Aug 2, 2019 | 94 | Order (3) Docket Text: ORDER, On or before August 13, 2019, the parties shall each file a three-page letter (in 14-point, Times New Roman font) informing the Court what effect, if any, the announced merger has on Mylan's pending motion as well as on this litigation, including but not limited to Mylan's status as a West Virginia corporation and its status as the holder of the relevant AND As in this case. Additionally, given the Court's present inclination to transfer the case against Mylan to the Northern District of West Virginia as well as its understanding that Defendant 3M Company consents to transfer to the Northern District, see D.I. 33 at 3, Plaintiffs AstraZeneca AB and AstraZeneca Pharmaceuticals LP, in their letter, shall inform the Court whether they consent to the transfer of the claims against 3M Company to the Northern District. Signed by Judge Colm F. Connolly on 8/2/2019. (nmf) |
| Aug 2, 2019 | 95 | Stipulation to EXTEND Time (2) Docket Text: STIPULATION TO EXTEND TIME for the Parties to: (1) submit the Joint Claim Construction Chart and (2) submit their position regarding word limits for Claim Construction briefing to Monday, August 5, 2019 (from Friday, August 2, 2019) - filed by AstraZeneca AB, AstraZeneca Pharmaceuticals LP. (Silver, Daniel) |
| Jul 31, 2019 | 93 | Stipulation to EXTEND Time (2) Docket Text: STIPULATION TO EXTEND TIME to Submit the Joint Claim Construction Chart to August 2, 2019 - filed by 3M Company, Mylan Inc.. (Ewing, Alexandra) |
| Jul 29, 2019 | 91 | Notice of Service (4) Docket Text: NOTICE OF SERVICE of PLAINTIFFS IDENTIFICATION OF INTRINSIC EVIDENCE IN OPPOSITION TO DEFENDANTS PROPOSED CONSTRUCTIONS filed by AstraZeneca AB, AstraZeneca Pharmaceuticals LP.(Silver, Daniel) |
| Jul 29, 2019 | 92 | Notice of Service (2) Docket Text: NOTICE OF SERVICE of Defendants Mylan Pharmaceuticals Inc. and 3M Company's list of term(s)/phrase(s) in issue and list of the rebuttal evidence on which Defendants intend to rely filed by 3M Company, Mylan Pharmaceuticals Inc..(Ewing, Alexandra) |
| Jul 25, 2019 | 88 | Notice of Service (4) Docket Text: NOTICE OF SERVICE of Plaintiffs' Preliminary Constructions and Identification of Intrinsic Evidentiary Support filed by AstraZeneca AB, AstraZeneca Pharmaceuticals LP.(Silver, Daniel) |
| Jul 25, 2019 | 89 | Notice of Service (2) Docket Text: NOTICE OF SERVICE of (1) Defendant Mylan Pharmaceuticals Inc.'s First Amended Objections and Responses to Plaintiffs' First Set of Requests for the Production of Documents and Things to Mylan (Nos. 1-62) and (2) Defendant 3M Company's First Amended Objections and Responses to Plaintiffs' First Set of Requests for the Production of Documents and Things to 3M (Nos. 1-60) filed by 3M Company, Mylan Pharmaceuticals Inc..(Ewing, Alexandra) |
| Jul 25, 2019 | 90 | Notice of Service (2) Docket Text: NOTICE OF SERVICE of Defendants Mylan Pharmaceuticals Inc. and 3M Company's proposed constructions and identification of intrinsic evidentiary support filed by 3M Company, Mylan Pharmaceuticals Inc..(Ewing, Alexandra) |
| Jul 22, 2019 | 87 | Notice of Service (4) Docket Text: NOTICE OF SERVICE of Plaintiffs' Objections and Responses to Defendants' First Set of Common Interrogatories to Plaintiffs (Nos. 1-10) filed by AstraZeneca AB, AstraZeneca Pharmaceuticals LP.(Silver, Daniel) |
| Jul 19, 2019 | 85 | Notice of Service (4) Docket Text: NOTICE OF SERVICE of Plaintiffs List of Proposed Claim Terms for Construction filed by AstraZeneca AB, AstraZeneca Pharmaceuticals LP.(Silver, Daniel) |
| Jul 19, 2019 | 86 | Notice of Service (2) Docket Text: NOTICE OF SERVICE of Defendants Mylan Pharmaceuticals Inc. and 3M Company's proposed terms for construction filed by 3M Company, Mylan Pharmaceuticals Inc..(Ewing, Alexandra) |
| Jul 16, 2019 | 84 | Notice of Service (2) Docket Text: NOTICE OF SERVICE of Defendants Mylan Pharmaceuticals Inc. and 3M Company's Invalidity Contentions and the Document Production Accompanying Invalidity Contentions filed by 3M Company, Mylan Pharmaceuticals Inc..(Ewing, Alexandra) |
| Jul 1, 2019 | 83 | Notice of Service (2) Docket Text: NOTICE OF SERVICE of PLAINTIFFS OBJECTIONS AND RESPONSES TO DEFENDANTS FIRST SET OF REQUESTS FOR THE PRODUCTION OF DOCUMENTS AND THINGS (NOS. l122) filed by AstraZeneca AB, AstraZeneca Pharmaceuticals LP.(Silver, Daniel) |
| Jun 26, 2019 | 82 | Order Setting Teleconference (4) Docket Text: ORDER Setting Teleconference: Plaintiffs' counsel to initiate the call. A Telephone Conference is set for 8/5/2019 at 11:30 AM before Judge Mary Pat Thynge to discuss ADR. Signed by Judge Mary Pat Thynge on 6/26/19. Associated Cases: 1:18-cv-01562-CFC, 1:18-cv-01685-CFC(cak) |
| Jun 24, 2019 | 81 | Notice of Service (2) Docket Text: NOTICE OF SERVICE of Defendant's First Set of Common Interrogatories to Plaintiffs (Nos. 1-10) filed by Catalent Pharma Solutions, LLC, Teva Pharmaceuticals USA, Inc..(Hoeschen, Nathan) |
| Jun 21, 2019 | 80 | Notice of Service (2) Docket Text: NOTICE OF SERVICE of Defendants' First Set of Common Interrogatories to Plaintiffs (Nos. 1-10) filed by 3M Company, Mylan Pharmaceuticals Inc..(Ewing, Alexandra) |
| Jun 19, 2019 | 79 | Protective Order (23) Docket Text: STIPULATED PROTECTIVE ORDER. Signed by Judge Colm F. Connolly on 6/19/2019. Associated Cases: 1:18-cv-01562-CFC, 1:18-cv-01685-CFC(fms) |
| Jun 17, 2019 | N/A | SO ORDERED (0) |
| Jun 17, 2019 | 78 | Proposed Order (23) Docket Text: PROPOSED ORDER Stipulated Protective Order by AstraZeneca AB, AstraZeneca Pharmaceuticals LP. (Silver, Daniel) |
| Jun 14, 2019 | 77 | Stipulation to EXTEND Time (2) Docket Text: STIPULATION TO EXTEND TIME for the parties to Submit Proposed Protective Order to June 17, 2019 - filed by 3M Company, Mylan Pharmaceuticals Inc.. (Ewing, Alexandra) |
| Jun 13, 2019 | 76 | Notice of Service (2) Docket Text: NOTICE OF SERVICE of Defendants Mylan Pharmaceuticals Inc.'s and 3M Company's Objections and Responses to Plaintiffs' First Set of Specific Interrogatories to Mylan Defendant Group (Nos. 1-6) filed by 3M Company, Mylan Pharmaceuticals Inc..(Ewing, Alexandra) |
| Jun 11, 2019 | N/A | SO ORDERED (0) |
| Jun 11, 2019 | 74 | Redacted Document (30) Docket Text: REDACTED VERSION of [71] Amended Complaint, by AstraZeneca AB, AstraZeneca Pharmaceuticals LP. (Silver, Daniel) |
| Jun 11, 2019 | 75 | Redacted Document (30) Docket Text: REDACTED VERSION of [67] Stipulation by AstraZeneca AB, AstraZeneca Pharmaceuticals LP. (Silver, Daniel) |
| Jun 11, 2019 | 74 | Amended Complaint* (1) |
| Jun 10, 2019 | 73 | Stipulation to EXTEND Time (2) Docket Text: STIPULATION TO EXTEND TIME for the Parties to Submit Proposed Protective Order to Friday, June 14, 2019 (from Monday June 10, 2019) - filed by AstraZeneca AB, AstraZeneca Pharmaceuticals LP. (Silver, Daniel) |
| Jun 4, 2019 | N/A | CORRECTING ENTRY: (0) |
| Jun 4, 2019 | 72 | Notice of Service (4) Docket Text: NOTICE OF SERVICE of Plaintiffs' Asserted Claims and Infringement Contentions Against Defendants filed by AstraZeneca AB, AstraZeneca Pharmaceuticals LP.(Silver, Daniel) |
| May 31, 2019 | N/A | Patent Report Notice (0) Docket Text: NOTICE TO COUNSEL RE: SECOND AMENDED COMPLAINT AND PATENT REPORT: Counsel should file the Second Amended Complaint electronically with the court as the attachment to the stipulation appears to be missing exhibits. Also, please note that if patents are being added to this case through the SECOND AMENDED COMPLAINT referenced in D.I. [67] and [68], the filing party should complete the Report to Commissioner of Patents & Trademarks, and enter it on the docket using the PATENT/TRADEMARK REPORT event in the OTHER DOCUMENT list. The patent report form can be found at www.ded.uscourts.gov under the Clerk's Office FORMS button. (fms) |
| May 31, 2019 | 69 | Notice of Service (2) Docket Text: NOTICE OF SERVICE of Defendants' First Set of Requests for the Production of Documents and Things (Nos. 1-122) filed by 3M Company, Mylan Pharmaceuticals Inc..(Rawnsley, Jason) |
| May 31, 2019 | 70 | Patent/Trademark Report to Commissioner (1) Docket Text: Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 7,759,328 ;8,143,239 ;8,575,137 ;7,967,011 ;10,166,247 . (Silver, Daniel) Modified on 6/4/2019 (fms). |
| May 21, 2019 | N/A | Case Referred to Mediation (0) Docket Text: CASE REFERRED to Chief Magistrate Judge Mary Pat Thynge for Mediation. Please see Standing Order dated January 20, 2016, regarding disclosure of confidential ADR communications. A link to the standing order is provided here for your convenience at http://www.ded.uscourts.gov/general-orders/magistrate-judges-standing-order-adr-mediation Associated Cases: 1:18-cv-01562-CFC, 1:18-cv-01685-CFC(cak) |
| May 20, 2019 | 66 | Scheduling Order (18) Docket Text: SCHEDULING ORDER: Case referred to the Magistrate Judge for the purpose of exploring ADR. Joinder of Parties due by 8/30/2019. Amended Pleadings due by 8/30/2019. Fact Discovery completed by 11/1/2019. Joint Claim Construction Brief due by 10/2/2019. A Markman Hearing is set for 12/4/2019 at 09:00 AM in Courtroom 4B before Judge Colm F. Connolly. A Final Pretrial Conference is set for 6/2/2020 at 04:00 PM in Courtroom 4B before Judge Colm F. Connolly. A Bench Trial is set for 6/15/2020 at 09:00 AM in Courtroom 4B before Judge Colm F. Connolly. Signed by Judge Colm F. Connolly on 5/20/2019. Associated Cases: 1:18-cv-01562-CFC, 1:18-cv-01685-CFC(nmf) |
| May 17, 2019 | 64 | Notice of Service (4) Docket Text: NOTICE OF SERVICE of (1) Plaintiffs AstraZeneca AB and AstraZeneca Pharmaceuticals LPs Initial Disclosures Pursuant to Rule 26(a)(1); (2) Plaintiffs Initial Disclosures Identifying Defendants Accused Products and Plaintiffs Asserted Patents; and (3) Plaintiffs Initial Disclosures Pursuant to Paragraph 3 of The Default Standard for Discovery filed by AstraZeneca AB, AstraZeneca Pharmaceuticals LP.(Silver, Daniel) |
| May 17, 2019 | 65 | Notice of Service (2) Docket Text: NOTICE OF SERVICE of Defendant Mylan Pharmaceuticals Inc.'s and 3M Company's Discovery Disclosures and Defendant Mylan Pharmaceuticals Inc.'s and 3M Company's Objections and Responses to Plaintiff's First Set of Common Interrogatories (Nos. 1-6) filed by 3M Company, Mylan Pharmaceuticals Inc..(Ewing, Alexandra) |
| May 15, 2019 | 63 | Proposed Order (18) Docket Text: PROPOSED ORDER Scheduling by AstraZeneca AB, AstraZeneca Pharmaceuticals LP. (Silver, Daniel) |
| May 14, 2019 | 62 | Notice of Service (2) Docket Text: NOTICE OF SERVICE of Plaintiffs First Set of Specific Interrogatories to Mylan Defendant Group (Nos. 1-6) filed by AstraZeneca AB, AstraZeneca Pharmaceuticals LP.(Silver, Daniel) |
| May 10, 2019 | 61 | Notice of Service (2) Docket Text: NOTICE OF SERVICE of Defendant Mylan Pharmaceuticals Inc.'s Objections and Responses to Plaintiffs' First Set of Requests for the Production of Documents and Things to Mylan (Nos. 1-62) and Defendant 3M Company's Objections and Responses to Plaintiffs' First Set of Requests for the Production of Documents and Things to 3M (Nos. 1-60) filed by 3M Company, Mylan Pharmaceuticals Inc..(Ewing, Alexandra) |
| Apr 17, 2019 | 60 | Notice of Service (4) Docket Text: NOTICE OF SERVICE of Plaintiffs' First Set of Common Interrogatories (Nos. 1-6) filed by AstraZeneca AB, AstraZeneca Pharmaceuticals LP.(Silver, Daniel) |
| Apr 15, 2019 | N/A | Scheduling Conference (0) Docket Text: Minute Entry for proceedings held before Judge Colm F. Connolly - Scheduling Conference held on 4/15/2019. (Court Reporter V. Gunning.) Counsel to submit the final proposed scheduling order to the Court. Associated Cases: 1:18-cv-01562-CFC, 1:18-cv-01685-CFC(nmf) |
| Apr 12, 2019 | 59 | Proposed Order (14) Docket Text: PROPOSED ORDER Scheduling by AstraZeneca AB, AstraZeneca Pharmaceuticals LP. (Silver, Daniel) |
| Apr 10, 2019 | 58 | Notice of Service (2) Docket Text: NOTICE OF SERVICE of (1) Plaintiffs First Set of Requests for Production of Documents and Things to Mylan (Nos. 1-62), (2) Plaintiffs First Set of Requests for Production of Documents and Things to 3M (Nos. 1-60) filed by AstraZeneca AB, AstraZeneca Pharmaceuticals LP.(Silver, Daniel) |
| Apr 9, 2019 | 57 | Letter (3) Docket Text: Letter to The Honorable Colm F. Connolly from Daniel M. Silver, Esq.. (Silver, Daniel) |
| Apr 2, 2019 | 56 | Redacted Document (23) Docket Text: REDACTED VERSION of [49] Reply Brief, by 3M Company, Mylan Pharmaceuticals Inc.. (Ewing, Alexandra) |
| Mar 28, 2019 | 53 | Redacted Document (30) Docket Text: REDACTED VERSION of [39] Answering Brief in Opposition, by AstraZeneca AB, AstraZeneca Pharmaceuticals LP. (Silver, Daniel) |
| Mar 28, 2019 | 54 | Redacted Document (4) Docket Text: REDACTED VERSION of [40] Declaration by AstraZeneca AB, AstraZeneca Pharmaceuticals LP. (Silver, Daniel) |
| Mar 28, 2019 | 55 | Redacted Document (10) Docket Text: REDACTED VERSION of [41] Declaration by AstraZeneca AB, AstraZeneca Pharmaceuticals LP. (Silver, Daniel) |
| Mar 26, 2019 | 52 | Request for Oral Argument (1) Docket Text: REQUEST for Oral Argument by AstraZeneca AB, AstraZeneca Pharmaceuticals LP re [19] MOTION to Dismiss for Failure to State a Claim and Improper Venue, [32] MOTION to Transfer Case to Northern District of West Virginia MOTION to Dismiss for Failure to Join a Party . (Silver, Daniel) |
| Mar 22, 2019 | N/A | SO ORDERED (0) |
| Mar 21, 2019 | 51 | Stipulation to EXTEND Time (2) Docket Text: STIPULATION TO EXTEND TIME for the Plaintiffs to Submit Redacted Versions of (1) Plaintiffs' Consolidated Opposition to the Mylan Defendants' Motion to Dismiss for Failure to State a Claim and Improper Venue and 3M's Motion to Dismiss or Transfer Venue, (2) Declaration of Domenick Fanelli; and (3) Declaration of Anna Q. Han to Thursday, March 28, 2019 (from Thursday, March 21, 2019) - filed by AstraZeneca AB, AstraZeneca Pharmaceuticals LP. (Silver, Daniel) |
| Mar 20, 2019 | N/A | SO ORDERED (0) |
| Mar 19, 2019 | 48 | Motion for Leave to Appear Pro Hac Vice (3) Docket Text: MOTION for Pro Hac Vice Appearance of Attorney David L. Anstaett - filed by 3M Company. (Ewing, Alexandra) |
| Mar 19, 2019 | 49 | Reply Brief (23) Docket Text: REPLY BRIEF re [19] MOTION to Dismiss for Failure to State a Claim and Improper Venue, [32] MOTION to Transfer Case to Northern District of West Virginia MOTION to Dismiss for Failure to Join a Party filed by 3M Company, Mylan Pharmaceuticals Inc.. (Cottrell, Frederick) Modified on 10/11/2019 (nmf). |
| Mar 19, 2019 | 50 | Declaration (2) |
| Mar 19, 2019 | 50 | Exhibit 1-4 (80) |
| Mar 19, 2019 | 50 | Main Document (2) Docket Text: DECLARATION re [49] Reply Brief, (Declaration of Emily J. Greb) by 3M Company, Mylan Pharmaceuticals Inc.. (Attachments: # (1) Exhibit 1-4)(Cottrell, Frederick) |
| Mar 18, 2019 | N/A | SO ORDERED (0) |
| Mar 18, 2019 | N/A | Add Attorneys Pro Hac Vice (0) |
| Mar 14, 2019 | 46 | SO ORDERED (3) Docket Text: SO ORDERED, re [45] Stipulation of Dismissal filed by Mylan N.V., Mylan Laboratories Limited, Mylan Inc., Party Mylan N.V., Mylan Inc. and Mylan Laboratories Limited terminated. Signed by Judge Colm F. Connolly on 3/13/2019. (fms) Modified on 3/14/2019 (fms). |
| Mar 14, 2019 | 47 | Stipulation to EXTEND Time (2) Docket Text: STIPULATION TO EXTEND TIME for the Plaintiffs to Submit Redacted Versions of (1) Plaintiffs' Consolidated Opposition to the Mylan Defendants' Motion to Dismiss for Failure to State a Claim and Improper Venue and 3M's Motion to Dismiss or Transfer Venue, (2) Declaration of Domenick Fanelli; and (3) Declaration of Anna Q. Han to Thursday, March 21, 2019 (from Thursday, March 14, 2019) - filed by AstraZeneca AB, AstraZeneca Pharmaceuticals LP. (Silver, Daniel) |
| Mar 13, 2019 | 45 | Stipulation of Dismissal (3) Docket Text: STIPULATION of Dismissal Regarding Dismissal of Certain Defendants by Mylan Inc., Mylan Laboratories Limited, Mylan N.V.. (Cottrell, Frederick) |
| Mar 8, 2019 | N/A | SO ORDERED (0) |
| Mar 8, 2019 | 44 | Order Setting Scheduling Conference (2) Docket Text: Order Setting Scheduling Conference: A Scheduling Conference is set for 4/15/2019 at 03:00 PM in Chambers before Judge Colm F. Connolly. Signed by Judge Colm F. Connolly on 3/8/2019. Associated Cases: 1:18-cv-01562-CFC, 1:18-cv-01685-CFC(nmf) |
| Mar 7, 2019 | 43 | Stipulation to EXTEND Time (2) Docket Text: STIPULATION TO EXTEND TIME to file redactions to DI. 39, 40 and 41 to March 14, 2019 - filed by 3M Company, Mylan Inc., Mylan Laboratories Limited, Mylan N.V., Mylan Pharmaceuticals Inc.. (Ewing, Alexandra) |
| Mar 5, 2019 | N/A | Add Attorneys Pro Hac Vice (0) |
| Mar 5, 2019 | 42 | Letter (1) Docket Text: Letter to The Honorable Colm F. Connolly from Daniel M. Silver, Esq. regarding Proposed Scheduling Order - re (37 in 1:18-cv-01562-CFC, 37 in 1:18-cv-01562-CFC, 19 in 1:18-cv-01685-CFC, 19 in 1:18-cv-01685-CFC) Order,, Set Deadlines,. (Silver, Daniel) |
| Feb 28, 2019 | 40 | Declaration (3) |
| Feb 28, 2019 | 40 | Certificate of Service (1) |
| Feb 28, 2019 | 40 | Main Document (3) Docket Text: DECLARATION re [39] Answering Brief in Opposition, of Domenick Fanelli by AstraZeneca AB, AstraZeneca Pharmaceuticals LP. (Attachments: # (1) Certificate of Service)(Silver, Daniel) Modified on 10/11/2019 (nmf). |
| Feb 22, 2019 | N/A | SO ORDERED (0) |
| Feb 21, 2019 | 38 | Certifications for Douglas A. Behrens (1) |
| Feb 21, 2019 | 38 | Main Document (2) Docket Text: MOTION for Pro Hac Vice Appearance of Attorney Douglas A. Behrens - filed by AstraZeneca AB, AstraZeneca Pharmaceuticals LP. (Attachments: # (1) Certifications for Douglas A. Behrens)(Silver, Daniel) |
| Feb 19, 2019 | 37 | Order (2) Docket Text: ORDER, IT IS ORDERED that, on or before March 5, 2019, counsel for plaintiffs shall inform the court as to whether the need for coordinated discovery and/or Markman proceedings is anticipated as to the above cases and, if so, when a joint scheduling conference might most efficiently be conducted. ORDER, Setting Deadlines: ( Notice of Compliance deadline set for 3/5/2019.) Signed by Judge Colm F. Connolly on 2/19/2019. Associated Cases: 1:18-cv-01562-CFC, 1:18-cv-01685-CFC(nmf) |
| Feb 4, 2019 | 36 | SO ORDERED (2) Docket Text: SO ORDERED, re [35] Stipulation filed by AstraZeneca Pharmaceuticals LP, AstraZeneca AB. Set Briefing Schedule: re [19] MOTION to Dismiss for Failure to State a Claim and Improper Venue, [32] MOTION to Transfer Case to Northern District of West Virginia MOTION to Dismiss for Failure to Join a Party . (Answering Brief due 2/28/2019., Reply Brief due 3/19/2019.). See Stipulation for further details. Signed by Judge Colm F. Connolly on 2/4/2019. (fms) |
| Feb 1, 2019 | 35 | Stipulation (2) Docket Text: STIPULATION and [Proposed] Order Regarding Briefing on Motions to Dismiss re [19] MOTION to Dismiss for Failure to State a Claim and Improper Venue, [32] MOTION to Transfer Case to Northern District of West Virginia MOTION to Dismiss for Failure to Join a Party by AstraZeneca AB, AstraZeneca Pharmaceuticals LP. (Joyce, Alexandra) |
| Jan 24, 2019 | 32 | Text of Proposed Order (1) |
| Jan 24, 2019 | 33 | Opening Brief in Support (17) Docket Text: OPENING BRIEF in Support re [32] MOTION to Transfer Case to Northern District of West Virginia MOTION to Dismiss for Failure to Join a Party filed by 3M Company.Answering Brief/Response due date per Local Rules is 2/7/2019. (Cottrell, Frederick) |
| Jan 24, 2019 | 34 | Disclosure Statement (1) Docket Text: Disclosure Statement pursuant to Rule 7.1: No Parents or Affiliates Listed filed by 3M Company. (Cottrell, Frederick) |
| Jan 24, 2019 | 32 | Main Document (1) Docket Text: MOTION to Transfer Case to Northern District of West Virginia, MOTION to Dismiss for Failure to Join a Party - filed by 3M Company. (Attachments: # (1) Text of Proposed Order)(Cottrell, Frederick) |
| Jan 23, 2019 | N/A | SO ORDERED (0) |
| Jan 22, 2019 | N/A | Add Attorneys Pro Hac Vice (0) |
| Jan 18, 2019 | N/A | SO ORDERED (0) |
| Jan 18, 2019 | 30 | Stipulation to EXTEND Time (2) Docket Text: STIPULATION TO EXTEND TIME Plaintiffs' Deadline to Submit an Answering Brief to Defendants' Motion to Dismiss for Failure to State a Claim and Improper Venue to Thursday, February 21, 2019 - filed by AstraZeneca AB, AstraZeneca Pharmaceuticals LP. (Silver, Daniel) |
| Jan 18, 2019 | 31 | Motion for Leave to Appear Pro Hac Vice (4) Docket Text: MOTION for Pro Hac Vice Appearance of Attorney Shannon M. Bloodworth and Emily J. Greb - filed by 3M Company. (Ewing, Alexandra) |
| Jan 17, 2019 | 27 | Notice of Appearance (1) Docket Text: NOTICE of Appearance by Alexandra M. Ewing on behalf of 3M Company (Ewing, Alexandra) |
| Jan 17, 2019 | 28 | Notice of Appearance (1) Docket Text: NOTICE of Appearance by Frederick L. Cottrell, III on behalf of 3M Company (Cottrell, Frederick) |
| Jan 17, 2019 | 29 | Notice of Appearance (1) Docket Text: NOTICE of Appearance by Jason James Rawnsley on behalf of 3M Company (Rawnsley, Jason) |
| Jan 15, 2019 | 26 | Redacted Document (7) |
| Jan 15, 2019 | 25 | Redacted Document (23) Docket Text: REDACTED VERSION of [20] Opening Brief in Support, by Mylan Inc., Mylan Laboratories Limited, Mylan N.V., Mylan Pharmaceuticals Inc.. (Ewing, Alexandra) |
| Jan 15, 2019 | 26 | Exhibit 1-3 (211) |
| Jan 15, 2019 | 26 | Main Document (7) Docket Text: REDACTED VERSION of [21] Declaration, by Mylan Inc., Mylan Laboratories Limited, Mylan N.V., Mylan Pharmaceuticals Inc.. (Attachments: # (1) Exhibit 1-3)(Ewing, Alexandra) |
| Jan 14, 2019 | 24 | Notice of Change of Address (2) Docket Text: NOTICE of Change of Address by Alexandra M. Ewing (Ewing, Alexandra) |
| Jan 10, 2019 | N/A | Add Attorneys Pro Hac Vice (0) |
| Jan 8, 2019 | N/A | SO ORDERED (0) |
| Jan 8, 2019 | 23 | Motion for Leave to Appear Pro Hac Vice (5) Docket Text: MOTION for Pro Hac Vice Appearance of Attorney Shannon M. Bloodworth, David L. Anstaett and Emily J. Greb - filed by Mylan Inc., Mylan Laboratories Limited, Mylan N.V., Mylan Pharmaceuticals Inc.. (Ewing, Alexandra) |
| Jan 7, 2019 | 21 | Declaration (7) |
| Jan 7, 2019 | 18 | Redacted Document (30) Docket Text: REDACTED VERSION of [13] Amended Complaint, by AstraZeneca AB, AstraZeneca Pharmaceuticals LP. (Silver, Daniel) |
| Jan 7, 2019 | 19 | Text of Proposed Order (1) |
| Jan 7, 2019 | 20 | Opening Brief in Support (23) Docket Text: OPENING BRIEF in Support re [19] MOTION to Dismiss for Failure to State a Claim and Improper Venue filed by Mylan Inc., Mylan Laboratories Limited, Mylan N.V., Mylan Pharmaceuticals Inc..Answering Brief/Response due date per Local Rules is 1/22/2019. (Cottrell, Frederick) Modified on 10/11/2019 (nmf). |
| Jan 7, 2019 | 21 | Exhibit 1-3 (213) |
| Jan 7, 2019 | 22 | Disclosure Statement (2) Docket Text: Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent Mylan N.V. for Mylan Inc.; Corporate Parent Mylan Inc. for Mylan Laboratories Limited, Mylan Pharmaceuticals Inc. filed by Mylan Inc., Mylan Laboratories Limited, Mylan N.V., Mylan Pharmaceuticals Inc.. (Cottrell, Frederick) |
| Jan 7, 2019 | 19 | Main Document (2) Docket Text: MOTION to Dismiss for Failure to State a Claim and Improper Venue - filed by Mylan Inc., Mylan Laboratories Limited, Mylan N.V., Mylan Pharmaceuticals Inc.. (Attachments: # (1) Text of Proposed Order)(Cottrell, Frederick) |
| Jan 7, 2019 | 21 | Main Document (7) Docket Text: DECLARATION re [19] MOTION to Dismiss for Failure to State a Claim and Improper Venue, [20] Opening Brief in Support, (Declaration of Keith Meckstroth) by Mylan Inc., Mylan Laboratories Limited, Mylan N.V., Mylan Pharmaceuticals Inc.. (Attachments: # (1) Exhibit 1-3)(Cottrell, Frederick) Modified on 10/11/2019 (nmf). |
| Jan 4, 2019 | 17 | Summons Returned Executed (2) Docket Text: SUMMONS Returned Executed by AstraZeneca AB, AstraZeneca Pharmaceuticals LP. 3M Company served on 1/3/2019, answer due 1/24/2019. (Silver, Daniel) |
| Jan 3, 2019 | N/A | Summons Reissued (0) Docket Text: Summons Reissued with Magistrate Consent Notice attached as to 3M Company. (sar) |
| Jan 2, 2019 | N/A | SO ORDERED (0) |
| Dec 31, 2018 | 16 | Stipulation to EXTEND Time (2) Docket Text: STIPULATION TO EXTEND TIME to move, answer or otherwise respond to Plaintiffs' First Amended Complaint to January 7, 2019 - filed by Mylan Inc., Mylan Laboratories Limited, Mylan N.V., Mylan Pharmaceuticals Inc.. (Ewing, Alexandra) |
| Dec 27, 2018 | N/A | SO ORDERED (0) |
| Dec 26, 2018 | 15 | Stipulation to EXTEND Time (2) Docket Text: STIPULATION TO EXTEND TIME Regarding Extension of Time to File Redactions to the First Amended Complaint to January 4, 2019 - filed by 3M Company, Mylan Inc., Mylan Laboratories Limited, Mylan N.V., Mylan Pharmaceuticals Inc.. (Ewing, Alexandra) |
| Dec 20, 2018 | N/A | Summons Issued (0) Docket Text: Summons Issued with Magistrate Consent Notice attached as to 3M Company on 12/20/2018. (nmg) |
| Dec 20, 2018 | 14 | Summons Returned Executed (2) Docket Text: SUMMONS Returned Executed by AstraZeneca AB, AstraZeneca Pharmaceuticals LP. 3M Company served on 12/20/2018, answer due 1/10/2019. (Silver, Daniel) |
| Nov 27, 2018 | N/A | Add Attorneys Pro Hac Vice (0) |
| Nov 27, 2018 | 12 | Notice of Appearance (1) Docket Text: NOTICE of Appearance by Frederick L. Cottrell, III on behalf of Mylan Inc., Mylan Laboratories Limited, Mylan N.V., Mylan Pharmaceuticals Inc. (Cottrell, Frederick) |
| Nov 16, 2018 | N/A | SO ORDERED (0) |
| Nov 15, 2018 | N/A | SO ORDERED (0) |
| Nov 15, 2018 | 11 | Certification for Christopher N. Sipes, Gary M. Rubman, Matthew Kudzin and Anna (4) |
| Nov 15, 2018 | 11 | Main Document (2) Docket Text: MOTION for Pro Hac Vice Appearance of Attorney Christopher N. Sipes, Gary M. Rubman, Matthew Kudzin and Anna Q. Han - filed by AstraZeneca AB, AstraZeneca Pharmaceuticals LP. (Attachments: # (1) Certification for Christopher N. Sipes, Gary M. Rubman, Matthew Kudzin and Anna Q. Han)(Silver, Daniel) |
| Nov 14, 2018 | 10 | Stipulation to EXTEND Time (2) Docket Text: STIPULATION TO EXTEND TIME to move, answer or otherwise respond to Plaintiffs' Complaint to December 20, 2018 - filed by Mylan Inc., Mylan Laboratories Limited, Mylan N.V., Mylan Pharmaceuticals Inc.. (Rawnsley, Jason) |
| Nov 2, 2018 | N/A | SO ORDERED (0) |
| Nov 1, 2018 | 9 | Stipulation to EXTEND Time (2) Docket Text: STIPULATION TO EXTEND TIME to Answer Complaint to November 14, 2018 - filed by Mylan Inc., Mylan Laboratories Limited, Mylan N.V., Mylan Pharmaceuticals Inc.. (Ewing, Alexandra) |
| Oct 18, 2018 | 7 | Declaration (2) |
| Oct 18, 2018 | 7 | Exhibit A & B (5) |
| Oct 18, 2018 | 8 | Declaration (2) |
| Oct 18, 2018 | 8 | Exhibit A & B (6) |
| Oct 18, 2018 | 7 | Main Document (2) Docket Text: DECLARATION of Mailing regarding service on Mylan Pharmaceuticals Inc. made on October 17, 2018 by AstraZeneca AB, AstraZeneca Pharmaceuticals LP. (Attachments: # (1) Exhibit A & B)(Silver, Daniel) |
| Oct 18, 2018 | 8 | Main Document (2) Docket Text: DECLARATION of Mailing regarding service on Mylan Inc. made on October 11, 2018 by AstraZeneca AB, AstraZeneca Pharmaceuticals LP. (Attachments: # (1) Exhibit A & B)(Silver, Daniel) |
| Oct 17, 2018 | N/A | Case Assigned/Reassigned (0) Docket Text: Case Assigned to Judge Colm F. Connolly. Please include the initials of the Judge (CFC) after the case number on all documents filed. (rjb) |
| Oct 11, 2018 | N/A | Summons Issued (0) |
| Oct 11, 2018 | 1 | Complaint (39) |
| Oct 11, 2018 | 1 | Exhibits A-D (85) |
| Oct 11, 2018 | 1 | Civil Cover Sheet (1) |
| Oct 11, 2018 | 2 | Magistrate Consent Forms (3) Docket Text: Notice, Consent and Referral forms re: U.S. Magistrate Judge jurisdiction. (ceg) |
| Oct 11, 2018 | 3 | ANDA Form (2) Docket Text: Supplemental information for patent cases involving an Abbreviated New Drug Application (ANDA) - Date Patentee(s) Received Notice: 8/30/2018. Date of Expiration of Patent: see attached.Thirty Month Stay Deadline: 3/1/2021. (ceg) |
| Oct 11, 2018 | 4 | Patent/Trademark Report to Commissioner (1) Docket Text: Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 7,759,328; 8,143,239; 8,575,137; 7,967,011. (ceg) |
| Oct 11, 2018 | 5 | Disclosure Statement (2) Docket Text: Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent AstraZeneca PLC for AstraZeneca AB filed by AstraZeneca AB. (ceg) |
| Oct 11, 2018 | 6 | Disclosure Statement (2) Docket Text: Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent AstraZeneca PLC for AstraZeneca Pharmaceuticals LP filed by AstraZeneca Pharmaceuticals LP. (ceg) |
| Oct 11, 2018 | 1 | Main Document (39) Docket Text: COMPLAINT FOR PATENT INFRINGEMENT filed against Mylan Inc., Mylan Laboratories Limited, Mylan N.V., Mylan Pharmaceuticals Inc. - Magistrate Consent Notice to Pltf. ( Filing fee $ 400, receipt number 0311-2479128.) - filed by AstraZeneca AB, AstraZeneca Pharmaceuticals LP. (Attachments: # (1) Exhibits A-D, # (2) Civil Cover Sheet)(ceg) |
| Oct 11, 2018 | 1 | Complaint* (1) |
